Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-01-15
著者
-
Mandrioli Roberto
Faculty Of Pharmacy Department Of Pharmaceutical Sciences Alma Mater Studiorum-university Of Bologna
-
Raggi Maria
Pharmaco-toxicological Analysis Laboratory Department Of Pharmaceutical Sciences
-
Raggi Maria
Faculty Of Pharmacy Department Of Pharmaceutical Sciences Alma Mater Studiorum - University Of Bolog
-
Mandrioli Roberto
Laboratory Of Pharmaco-toxicological Analysis Department Of Pharmaceutical Sciences Faculty Of Pharm
-
Mercolini Laura
Laboratory Of Pharmaco-toxicological Analysis Department Of Pharmaceutical Sciences Faculty Of Pharm
-
Boncompagni Giancarlo
Psychiatric Diagnosis And Care Services "m. Malpighi" Hospital
-
LATEANA Domenico
Laboratory of Pharmaco-Toxicological Analysis, Department of Pharmaceutical Sciences, Faculty of Pha
-
RAGGI Maria
Laboratory of Pharmaco-Toxicological Analysis, Department of Pharmaceutical Sciences, Faculty of Pha
-
Lateana Domenico
Laboratory Of Pharmaco-toxicological Analysis Department Of Pharmaceutical Sciences Faculty Of Pharm
-
Raggi Maria
Laboratory Of Pharmaco-toxicological Analysis Department Of Pharmaceutical Sciences Faculty Of Pharm
関連論文
- HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma
- Simultaneous determination of the antipsychotic drugs levomepromazine and clozapine and their main metabolites in human plasma by a HPLC-UV method with solid-phase extraction
- Determination of duloxetine in human plasma by capillary electrophoresis with laser-induced fluorescence detection
- Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV
- Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection
- HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure
- Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes